Because GLP-1s suppress food noise and appetite, it can be common for folks to forgo eating, which can lead to nutrient gaps and lack of protein, which can contribute to muscle loss
Murphy, Michael H
The similar viewpoints were also supported by other critical reviews and clinical trials (5558), and inferred that GLP-1RA could be considered in patients at a high risk of, or with established cardiovascular diseases to improve the prognosis of cardiovascular events (especially nonfatal stroke), whilst SGLT2i could be recommended for patients with heart failure or chronic kidney diseases
Research shows that it might improve peripheral nerve damage, prevent cardiovascular diseases and alleviate dementia
Envio UE: Envio do armazm UE
Bendotti, G., Montefusco, L., Lunati, M